Literature DB >> 21372448

Established osteoporosis associated with high mortality after adjustment for age and co-mobidities in postmenopausal Japanese women.

Masataka Shiraki1, Tatsuhiko Kuroda, Shiro Tanaka.   

Abstract

OBJECTIVE: Osteoporosis has been reported to increase the risk of mortality. However, these reports did not evaluate the effects of co-mobidities and the severity of osteoporosis on mortality. The aim of our study was to determine whether or not major osteoporotic fractures contribute to the increased mortality risk in Japanese women.
METHOD: We conducted a prospective observational study. Risk factors contributing to mortality were assessed by Cox's proportional hazard model.
SUBJECTS: A total of 1,429 ambulatory postmenopausal female volunteers aged over 50 years old were enrolled in the study. Information was obtained from the subjects on baseline biochemical indices, bone mineral density (BMD), prevalent fractures, and co-morbidities. Mortality was assessed and confirmed by the certificates or hospital records. The subjects were classified into three categories in accordance with or without osteoporosis. The osteoporotic group was further categorized by the basis of the presence or absence of major osteoporotic fractures.
RESULTS: Mean age and SD of the participants were 66.5±9.3 (50-90) years old. The participants were followed for a total of 4.5±3.5 years (mean ± SD) and a total of 141 participants (9.9%) died during the observation. In addition to the traditional risks for mortality, such as age (Hazard ratio, 2.817, 95% CI, 2.237-3.560, p<0.0001), BMI (HR 0.504, 0.304-0.824, p=0.0061), prevalent malignancies (HR 2.885, 1.929-4.214, p<0.0001), dementia (HR 1.602, 1.027-2.450, p=0.038) and cardio-vascular disease (HR 1.878, 1.228-2.787, p=0.0043), the serum level of creatinine (HR 2.451, 1.107-5.284, p=0.027) and severity of osteoporosis (HR 1.390, 1.129-1.719, P=0.0018) were found to be significant independent risk factors for all-cause mortality.
CONCLUSION: These results emphasize the importance of osteoporotic fracture in terms of survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372448     DOI: 10.2169/internalmedicine.50.4437

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  9 in total

1.  Can antiosteoporotic therapy reduce mortality in MRI-proved acute osteoporotic vertebral fractures?

Authors:  Ying-Chou Chen; Fu-Mei Su; Tien-Tsai Cheng; Wei-Che Lin; Chun-Chung Lui
Journal:  J Bone Miner Metab       Date:  2015-06-04       Impact factor: 2.626

2.  Bone Mineral Density of the Radius Predicts All-Cause Mortality in Patients With Type 2 Diabetes: Diabetes Heart Study.

Authors:  Leon Lenchik; Thomas C Register; Fang-Chi Hsu; Jianzhao Xu; S Carrie Smith; J Jeffrey Carr; Barry I Freedman; Donald W Bowden
Journal:  J Clin Densitom       Date:  2017-12-01       Impact factor: 2.617

Review 3.  Osteoporosis and treatments in Japan: management for preventing subsequent fractures.

Authors:  Shuko Nojiri; Russel T Burge; Jennifer A Flynn; Shonda A Foster; Hideaki Sowa
Journal:  J Bone Miner Metab       Date:  2013-03-28       Impact factor: 2.626

4.  Adherence and persistence with once-daily teriparatide in Japan: a retrospective, prescription database, cohort study.

Authors:  Ikuko Tanaka; Masayo Sato; Tomoko Sugihara; Douglas E Faries; Shuko Nojiri; Peita Graham-Clarke; Jennifer A Flynn; Russel T Burge
Journal:  J Osteoporos       Date:  2013-12-12

5.  Treatment for Osteoporosis among Women in Japan: Associations with Patient Characteristics and Patient-Reported Outcomes in the 2008-2011 Japan National Health and Wellness Surveys.

Authors:  Masayo Sato; Jeffrey Vietri; Jennifer A Flynn; Saeko Fujiwara
Journal:  J Osteoporos       Date:  2014-12-23

6.  Risk of long-term infection-related death in clinical osteoporotic vertebral fractures: A hospital-based analysis.

Authors:  Ying-Chou Chen; Wei-Che Lin
Journal:  PLoS One       Date:  2017-08-09       Impact factor: 3.240

7.  Poor 1st-year adherence to anti-osteoporotic therapy increases the risk of mortality in patients with magnetic resonance imaging-proven acute osteoporotic vertebral fractures.

Authors:  Ying-Chou Chen; Wei-Che Lin
Journal:  Patient Prefer Adherence       Date:  2017-04-27       Impact factor: 2.711

8.  Is raloxifene associated with lower risk of mortality in postmenopausal women with vertebral fractures after vertebroplasty?: a hospital-based analysis.

Authors:  Fu-Mei Su; Ying-Chou Chen; Tien-Tsai Cheng; Wei-Che Lin; Chun-Chung Lui
Journal:  BMC Musculoskelet Disord       Date:  2015-08-19       Impact factor: 2.362

9.  Bone Strength and Arterial Stiffness Impact on Cardiovascular Mortality in a General Population.

Authors:  Petar Avramovski; Maja Avramovska; Aleksandar Sikole
Journal:  J Osteoporos       Date:  2016-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.